RxDoctor Payments Data

Ashley Boettcher

Family · Fort Wayne, INNPI 1437527892

Payments from drug & device makers

$2,931in general payments, 2019–2025

Across 132 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$901
  • Lilly USA, LLC$648
  • Otsuka America Pharmaceutical, Inc.$463
  • Axsome Therapeutics, Inc.$143
  • Exact Sciences$79
  • Sunovion Pharmaceuticals Inc.$68
  • plus $630 from 17 others

What the payments were for

  • Food & beverage$2,931100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,931 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin41$34,605
TrulicityDulaglutide24$25,903
Emgality PenGalcanezumab-Gnlm27$19,671
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$18,799
OzempicSemaglutide14$16,780
JanuviaSitagliptin Phosphate14$13,919
FarxigaDapagliflozin Propanediol15$12,320
MounjaroTirzepatide11$12,026
RybelsusSemaglutide12$12,020
Breo ElliptaFluticasone/Vilanterol18$8,087
Incruse ElliptaUmeclidinium Bromide13$4,779
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,125
Albuterol Sulfate HfaAlbuterol Sulfate75$1,281
Celecoxib22$770
Atorvastatin Calcium93$558

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$648$37,92935 claims
Novo NordiskOzempic, Rybelsus$33$28,80026 claims
MerckJanuvia$29$13,91914 claims
AstraZenecaFarxiga$60$12,32015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.

Other family in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →